Most middle aged adults could benefit from a short term treatment to revitalise the immune system and organs that deteriorate with age, say researchers
Scientists have hailed the success of a clinical trial which found that experimental anti-ageing drugs may protect older people from potentially fatal respiratory infections by rejuvenating their immune systems.
In a trial involving people aged 65 and over, those who received a combination therapy of two anti-ageing compounds reported nearly half the number of infections over the following year as a control group who received only placebos.
This post was syndicated from Health | The Guardian. Click here to read the full text on the original website.